stockrowIntuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Net margin
Intuitive Surgical, Inc.'s net margin over the twelve months to 30 September 2026 was 25.5%, down 2.8 percentage points from fiscal 2025 (28.4%). Over the past ten years it has ranged from 21.3% (fiscal 2022) to 30.8% (fiscal 2019); the current reading is higher than 73% of that period. That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Net margin, annual
Embed this chart
Annual newest first
| Period | Net margin | Change (points) |
|---|---|---|
| FY2025 | 28.4% | 0.57 |
| FY2024 | 27.8% | 2.57 |
| FY2023 | 25.2% | 3.99 |
| FY2022 | 21.3% | (8.60) |
| FY2021 | 29.9% | 5.52 |
| FY2020 | 24.3% | (6.47) |
| FY2019 | 30.8% | 0.51 |
| FY2018 | 30.3% | 8.91 |
| FY2017 | 21.4% | (5.90) |
| FY2016 | 27.3% | 2.59 |
Quarterly newest first
| Period | Net margin | Change (points) |
|---|---|---|
| Sep 2026 | 17.2% | (11.14) |
| Jun 2026 | 28.3% | (1.36) |
| Mar 2026 | 29.7% | 1.92 |
| Dec 2025 | 27.7% | (0.39) |
| 43 more quarters | Free account |
Against its own ten years
Net margin against peers
| Company | Net margin |
|---|---|
| RMD ResMed Inc. compare | 27.8% |
| ISRG Intuitive Surgical, Inc. | 25.5% |
| WST West Pharmaceutical Services, Inc. compare | 18.8% |
| COO The Cooper Companies, Inc. compare | 13.5% |
| ALC Alcon compare | 5.92% |
| BDX Becton, Dickinson and Company compare | 4.52% |
| SOLV Solventum Corporation compare | 1.91% |
| MDLN Medline Inc. compare | 1.84% |
| BAX Baxter International Inc. compare | −6.23% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 1.06% |
What Net margin is
Net Profit Margin tells an investor how much of each unit of revenue ends up as profit for shareholders after all costs, interest and taxes.
Net Income Allotted to Shareholders ÷ Revenue
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement